Loading…
Microbot Medical Inc. is projected to rise to $2.14 by 2027, a +24% move from its current price of $1.72. MBOT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $1.68 | $1.72 | $1.76 | +0.06% |
| Aug 5 | $1.67 | $1.72 | $1.78 | +0.11% |
| Aug 6 | $1.66 | $1.72 | $1.79 | +0.17% |
| Aug 7 | $1.65 | $1.72 | $1.80 | +0.22% |
| Aug 8 | $1.64 | $1.72 | $1.81 | +0.28% |
| Aug 9 | $1.64 | $1.73 | $1.82 | +0.33% |
| Aug 10 | $1.63 | $1.73 | $1.83 | +0.39% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.63 | $1.73 | $1.83 | +0.39% |
| Week 2 | $1.60 | $1.73 | $1.88 | +0.78% |
| Week 3 | $1.58 | $1.74 | $1.92 | +1.17% |
| Week 4 | $1.56 | $1.75 | $1.96 | +1.56% |
| Week 5 | $1.54 | $1.75 | $1.99 | +1.96% |
| Week 6 | $1.53 | $1.76 | $2.02 | +2.36% |
| Week 7 | $1.52 | $1.77 | $2.06 | +2.75% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Microbot Medical Inc. is a medical device company that engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations.
The company also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. Microbot Medical was founded in 2010 and is based in Hingham, Massachusetts. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures.
MBOT is a healthcare stock currently priced at $1.75 with a market capitalization of $117.54M, and it trades with a rank of 3981. The current price and market position place MBOT among smaller-cap healthcare device names. The forecasted path shows a rising trajectory over the coming years, moving from a neutral near term to a bullish multi-year outlook, with average prices expanding from $1.75 in 2026 to $2.65 by 2030 and toward $10.34 by 2050, accompanied by sizable projected ROIs.
A major floor 12.8% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.9% away) — a key level to hold.
The nearest ceiling, 13.4% above — a clean break opens room to run.
A major ceiling 52.3% above — clearing it would confirm fresh momentum.
Key MBOT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MBOT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.71 | Buy | $1.72 | Buy |
| MA 10 | $1.74 | Sell | $1.74 | Sell |
| MA 20 | $1.80 | Sell | $1.78 | Sell |
| MA 50 | $1.83 | Sell | $1.86 | Sell |
| MA 100 | $2.08 | Sell | $1.98 | Sell |
| MA 200 | $2.13 | Sell | $2.11 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.57 | Neutral |
| Stoch RSI (14) | 51.61 | Neutral |
| CCI (20) | -78.72 | Neutral |
| Williams %R (14) | -75.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -7.53 | Sell |
| Bollinger %B (20,2) | 0.24 | Neutral |
| Stochastic %K (14) | 25.00 | Neutral |
| TRIX (15) | -0.27 | Sell |
| Awesome (5,34) | -0.11 | Sell |
| Ultimate (7,14,28) | 38.27 | Neutral |
| Momentum (10) | -0.03 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 1.69 | Buy |
| ADX (14) | 16.10 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is Bearish, with RSI(14) at 40 and the price hovering below key averages. The 50-day simple moving average stands at $1.89, while the 200-day simple moving average is at $2.20, creating near-term resistance above the current price. Support is identified at $1.75, with a near-term resistance at $1.96.
The 30-day price range runs from $1.50 to $2.04, highlighting modest upside potential against the current level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.62 | $1.72 | $2.36 | 0% | Neutral | |
| $1.74 | $2.14 | $2.76 | +24% | Bullish | |
| $1.94 | $2.43 | $3.24 | +42% | Bullish | |
| $1.98 | $2.53 | $3.45 | +47% | Bullish | |
| $1.99 | $2.59 | $3.60 | +51% | Bullish | |
| $2.02 | $2.66 | $3.77 | +55% | Bullish | |
| $2.08 | $2.79 | $4.01 | +62% | Bullish | |
| $2.38 | $3.22 | $4.69 | +87% | Bullish | |
| $2.66 | $3.64 | $5.38 | +111% | Bullish | |
| $2.82 | $3.91 | $5.85 | +127% | Bullish | |
| $3.34 | $4.86 | $7.66 | +182% | Bullish | |
| $6.24 | $9.87 | $16.82 | +474% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.62 | $1.72 | $2.13 | +0.00% |
| September 2026 | $1.54 | $1.81 | $2.18 | +5.08% |
| October 2026 | $1.53 | $1.81 | $2.20 | +0.10% |
| November 2026 | $1.58 | $1.87 | $2.29 | +3.41% |
| December 2026 | $1.61 | $1.92 | $2.36 | +2.48% |
Click any year to see its month-by-month MBOT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, MBOT could reach as high as $2.36, with a base case around $1.72 and support toward $1.62 — roughly 0% from $1.72. A consolidation phase looks the most probable path here.
Expect MBOT to range from $1.74 to $2.76 through 2027. The $2.14 average target implies a +24% move from current prices. That is up +24% on the projected 2026 average. Momentum favours further upside here.
The MBOT price prediction for 2028 points to an average of $2.43 (low $1.94, high $3.24) — a potential gain of +42% on today's $1.72. Buyers look set to stay in control over this stretch.
In 2029, MBOT is projected to trade between $1.98 and $3.45, averaging $2.53 — a potential gain of +47% from today's $1.72. That is up +4% on the projected 2028 average. Momentum favours further upside here.
Microbot Medical Inc.'s 2030 outlook centres on $2.59, within a $1.99 to $3.60 range. That is up +2% on the projected 2029 average. That marks a +51% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, MBOT could reach as high as $3.77, with a base case around $2.66 and support toward $2.02 — roughly +55% from $1.72. Momentum favours further upside here.
Expect MBOT to range from $2.08 to $4.01 through 2032. The $2.79 average target implies a +62% move from current prices. That is up +5% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The MBOT price prediction for 2033 points to an average of $3.22 (low $2.38, high $4.69) — a potential gain of +87% on today's $1.72. Momentum favours further upside here.
In 2034, MBOT is projected to trade between $2.66 and $5.38, averaging $3.64 — a potential gain of +111% from today's $1.72. That is up +13% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Microbot Medical Inc.'s 2035 outlook centres on $3.91, within a $2.82 to $5.85 range. That is up +7% on the projected 2034 average. That marks a +127% change versus current levels. Momentum favours further upside here.
By 2040, MBOT could reach as high as $7.66, with a base case around $4.86 and support toward $3.34 — roughly +182% from $1.72. Buyers look set to stay in control over this stretch.
Expect MBOT to range from $6.24 to $16.82 through 2050. The $9.87 average target implies a +474% move from current prices. That is up +103% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in MBOT today (≈ 581.395349 MBOT) could be worth
$5,741.28
+$4,741.28 (+474%) by 2050 · US Dollar
Based on the average projected MBOT price of $9.87 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MBOTwould be worth at today's price.
$1,000 invested in MBOT on Jul 31, 2025 (≈ 395.256921 MBOT) would be worth
$679.84
-$320.16 (-32.0%) today · 0.68× · US Dollar
Based on a MBOT entry price of $2.53 vs. today's $1.72.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.71 | $1,005.85 | +0.6% |
| 1 month ago | $1.91 | $900.52 | -9.9% |
| 3 months ago | $2.1 | $819.05 | -18.1% |
| 6 months ago | $1.78 | $966.29 | -3.4% |
| 1 year ago | $2.53 | $679.84 | -32.0% |
| All time (5.0y) ago | $7.1 | $242.25 | -75.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MBOT forecast.
Our base-case forecast reaches $3.40 around 2034.
Implied market cap at $3.40: $228.36M
The multi-year forecast points to a bullish ascent from 2027 onward, with annual averages and ROI improving each year. In 2026 the average price is $1.75 with a neutral sentiment and 0 ROI, then rising to an average of $2.20 in 2027 (ROI 25.5) and $2.57 in 2028 (ROI 46.8). By 2030 the average is $2.65 with an ROI of 51.6 and bullish sentiment; the trajectory continues higher through 2035 (avg $4.05, ROI 131.6) and into 2040 (avg $5.23, ROI 199).
The pinnacle appears in 2050 with an average of $10.34 and a max of $18.09, representing an ROI of 491 and a bullish outlook. The forecast also shows year-by-year acceleration beyond 2032, culminating in strong upside by 2040 and 2050. These are estimates and not guarantees, and actual results can differ due to market dynamics and other factors.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $2.65 with an ROI of 51.6 and a bullish sentiment.
Near term, 2026 is neutral with an average of $1.75 and 0 ROI; longer-term years from 2027 onward are bullish, with rising averages and higher ROIs through 2050.
Yes. The 2050 forecast shows an average of $10.34 and a max of $18.09, with a bullish sentiment and a 491 ROI.
The 2040 forecast indicates an average price of $5.23 with a max of $8.44 and an ROI of 199, under a bullish sentiment.
Current price is $1.75 and market capitalization is $117.54M.
Microbot Medical Inc. Community Discussion
0Share your Microbot Medical Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.